Company profile: Rancho BioSciences
1.1 - Company Overview
Company description
- Provider of fee-for-service life science data curation and knowledge management, leveraging open-source tools and public domain data for Pharma, non-profit foundations, and academia. Services include data curation, data governance and models, bioinformatics analysis (including genetic variant annotation), workflows and pipelines, knowledge mining, and creation of target profiles to support research and development.
Products and services
- Bioinformatics Analysis: Engineers open-source-enabled analyses of biological datasets, especially genomic and genetic data, to support research and development across Pharma, non-profit foundations, and academia
- Data Curation: Constructs enterprise-grade organization and integration of disparate datasets from public domain and various sources for unified analysis and access across Pharma, non-profit foundations, and academia
- Data Governance and Models: Architects policy-driven frameworks that establish data management standards and engineers models for data analysis to ensure consistent, accessible datasets for research stakeholders
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Rancho BioSciences
Microarrays
HQ: United States
Website
- Description: Provider of microarray platforms and services for analyte testing, diagnostics, and personalized medicine, including pathway-focused gene expression arrays (MI PathArray), whole-genome microarrays (MI ReadyArray), DNA and protein/antibody arrays, assay development, and lab services for RNA profiling and microarray assays.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Microarrays company profile →
Seven Bridges
HQ: United States
Website
- Description: Provider of cloud-based infrastructure and data analytics for biomedical research, delivering the Seven Bridges Platform for storing, analyzing and interpreting bioinformatic data; BioInfoMiner for unsupervised genomic interpretation; RHEO for custom automation; GRAF for graph-based NGS variant calling; and ARIA for high-throughput molecular and health data cohort analysis at million-participant scale, with services and support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Seven Bridges company profile →
Genesis Genetics
HQ: United States
Website
- Description: Provider of preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS), delivering expert laboratory services to respected IVF centers across the country and worldwide for pre-implantation testing of embryos for inherited genetic abnormalities.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Genesis Genetics company profile →
Tavec Pharma
HQ: Canada
Website
- Description: Provider of injectable cancer therapies using exosome-mediated delivery technology. The company enables delivery by injection of anti-cancer molecules, including regulatory RNA, directly to cancer cells to disrupt growth and metastasis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tavec Pharma company profile →
Axenis
HQ: France
Website
- Description: Provider of humanized mouse models as preclinical tools in immunology for the pharmaceutical industry, biotechnology companies, and academic research, using new immunocompromised mouse strains permissive to human tissue xenograft transplantation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Axenis company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Rancho BioSciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Rancho BioSciences
2.2 - Growth funds investing in similar companies to Rancho BioSciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Rancho BioSciences
4.2 - Public trading comparable groups for Rancho BioSciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →